메뉴 건너뛰기




Volumn 20, Issue 16, 2010, Pages 4819-4824

Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site

Author keywords

Antiinflammatory; Cytokines; Drug like; Ketoamides; p38 MAP kinase; SAR

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; ALPHA KETOAMIDE; AMIDE; DORAMAPIMOD; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BINDING; PROTEIN KINASE INHIBITOR;

EID: 77955420030     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.06.102     Document Type: Article
Times cited : (23)

References (27)
  • 17
    • 0004099649 scopus 로고    scopus 로고
    • F.D. King, 2nd ed. The Royal Society of Chemistry
    • F.D. King, Medicinal Chemistry Principles and Practice 2nd ed. 2002 The Royal Society of Chemistry 76
    • (2002) Medicinal Chemistry Principles and Practice , pp. 76
  • 20
    • 77955427253 scopus 로고    scopus 로고
    • note
    • Models of p38 in the DFG-out and DFG-in conformations were generated from the X-ray crystal structures of BIRB-796 and one of its analogues (pdb1kv1.ent and pdb1kv2.ent) and SB203580 (pdb1au9.ent) respectively, using the docking Software GLIDE (v4.0, Schrödinger, Portland, OR).
  • 21
    • 77955419505 scopus 로고    scopus 로고
    • note
    • A refined receptor model of p38 MAP kinase, which includes the activation loop missing in the X-ray crystal structure (pdb1kv2.ent) bound to BIRB796, was built with the PRIME comparative modeling software package (v.1.2, Schrödinger, LLC, New York, USA) using the above X-ray crystal structure as a template. Compound 10 was then docked using the induced fit protocol (GLIDE v4.0 and PRIME v1.5, Schrödinger, LLC, New York, USA).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.